192 related articles for article (PubMed ID: 27865296)
1. Cardiovascular Disease Risk Associated With the Long-term Use of Depot Medroxyprogesterone Acetate.
Dilshad H; Yousuf RI; Shoaib MH; Jamil S; Khatoon H
Am J Med Sci; 2016 Nov; 352(5):487-492. PubMed ID: 27865296
[TBL] [Abstract][Full Text] [Related]
2. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
[TBL] [Abstract][Full Text] [Related]
3. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
4. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
Westhoff C
J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
Anwar M; Soejono SK; Maruo T; Abdullah N
Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism.
Garza-Flores J; De la Cruz DL; Valles de Bourges V; Sanchez-Nuncio R; Martinez M; Fuziwara JL; Pérez-Palacios G
Contraception; 1991 Jul; 44(1):61-71. PubMed ID: 1832626
[TBL] [Abstract][Full Text] [Related]
7. Effect of hormonal contraceptives on serum lipids: A prospective study.
Dilshad H; Ismail R; Naveed S; Usmanghani K; Alam MT; Sarwar G
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1379-82. PubMed ID: 27592475
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term use of depo-medroxyprogesterone acetate on lipid metabolism in Nepalese women.
Yadav BK; Gupta RK; Gyawali P; Shrestha R; Poudel B; Sigdel M; Jha B
Korean J Lab Med; 2011 Apr; 31(2):95-7. PubMed ID: 21474983
[TBL] [Abstract][Full Text] [Related]
9. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
[TBL] [Abstract][Full Text] [Related]
10. Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot-medroxyprogesterone acetate.
Kremer J; de Bruijn HW; Hindriks FR
Contraception; 1980 Oct; 22(4):359-67. PubMed ID: 7449384
[TBL] [Abstract][Full Text] [Related]
11. Deterioration in cardiometabolic risk markers in obese women during depot medroxyprogesterone acetate use.
Segall-Gutierrez P; Xiang AH; Watanabe RM; Trigo E; Stanczyk FZ; Liu X; Jurow R; Buchanan TA
Contraception; 2012 Jan; 85(1):36-41. PubMed ID: 22067800
[TBL] [Abstract][Full Text] [Related]
12. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
13. Effect of depo-medroxyprogesterone acetate on coagulation factors and serum lipids in Egyptian women.
Fahmy K; Khairy M; Allam G; Gobran F; Alloush M
Contraception; 1991 Oct; 44(4):431-44. PubMed ID: 1836755
[TBL] [Abstract][Full Text] [Related]
14. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
15. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica.
Oberle MW; Rosero-Bixby L; Irwin KL; Fortney JA; Lee NC; Whatley AS; Bonhomme MG
Int J Epidemiol; 1988 Dec; 17(4):718-23. PubMed ID: 2976059
[TBL] [Abstract][Full Text] [Related]
17. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
18. A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction.
Kongsayreepong R; Chutivongse S; George P; Joyce S; McCone JM; Garza-Flores J; Valles de Bourges V; de La Cruz DL; Perez-Palacios G; Rosseneu M
Contraception; 1993 Feb; 47(2):177-91. PubMed ID: 8449018
[TBL] [Abstract][Full Text] [Related]
19. Effect of the injectable contraceptive depot-medroxyprogesterone acetate on coagulation parameters in new users.
Melhado-Kimura V; Bizzacchi JMA; Quaino SKP; Montalvao S; Bahamondes L; Fernandes A
J Obstet Gynaecol Res; 2017 Jun; 43(6):1054-1060. PubMed ID: 28503774
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of lipids and blood pressure in relation to method of contraception in Latino women with prior gestational diabetes mellitus.
Xiang AH; Kawakubo M; Buchanan TA; Kjos SL
Diabetes Care; 2007 Aug; 30(8):1952-8. PubMed ID: 17519432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
